Join your colleagues from across the globe to influence the way in which NSTE-ACS patients are managed post-PCI.
On behalf of the International Society of Cardiovascular Pharmacotherapy (ISCP) and Radcliffe Medical Education, thank you for your interest in taking part in this innovative crowdsourcing project, made possible with an unrestricted educational grant from AstraZeneca.
You will appreciate the important role clinical guidelines play in the practice of medicine. However, they are often outdated in relation to the latest data and empirical evidence. To address this, we are taking a novel crowdsourcing approach to pool the insight and practices of cardiologists from across the globe and will distil the prevailing beliefs and practices in a consensus statement, which we are aiming to publish in a peer reviewed journal in early 2021. The specific area of focus is on the use of monotherapy and DAPT in NSTE-ACS patients at high bleeding risk.
Based upon critical emerging data, the ISCP, in partnership with Radcliffe Medical Education, proposes an innovative crowdsourcing methodology, to create and publish a sound practice-based consensus on the treatment of high bleeding risk NSTE-ACS patients, following PCI.
To help shape this we are looking to recruit thought-leader cardiologists and other prescribers from across the globe to complete this survey. Interested participants should:
Registration for this project has now closed.
We are currently analysing the data and looking forward to sharing the results with you later this year.
To execute this exciting project, the Steering Committee of leading, global experts in ACS, alongside the valuable input of the crowd, will develop practice-based consensus and high-quality educational material for global dissemination.
Professor of Cardiovascular Science at St George’s, University of London (SGUL), Honorary Consultant Cardiologist at St George’s Hospital, NHS Trust, London, UK and Director of the Cardiovascular and Cell Sciences Research Institute at SGUL. Immediate Past-President of ISCP (International Society of Cardiovascular Pharmacotherapy)
Executive Director of Interventional Cardiovascular Programs, Brigham and Women’s Hospital Heart & Vascular Center, Professor of Medicine, Harvard Medical School
Director Catheterization Laboratory, King Fahd Armed Forces Hospital, Jeddah, Kingdom of Saudi Arabia, SCAI International Ambassador, ACC Interventional Leadership Council
Professor of Cardiovascular Medicine, Institute of Cardiology, Catholic University Medical School, Rome, Italy
Professor of Medicine, Director, Cardiovascular Research, Program Director, Interventional Cardiology Fellowship, University of Florida College of Medicine
Professor of Cardiovascular Clinical Pharmacology, King’s College London, London, UK
Consultant Cardiologist, East and North Hertfordshire NHS Trust & Professor of Cardiovascular Medicine, University of Hertfordshire, UK
President of the Argentine Federation of Cardiology, Co-Director, DAMIC Medical Institute / Rusculleda Foundation for Research in Medicine, Argentina
Professor of Cardiology, Keele University, UK
Head of Department of Epidemiology and Preventive Medicine, Head of School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
Professor of University of Sao Paulo, Brazil & Director of Acute Coronary Diseases Unit, Heart Institute (InCor)
Chief, Department of Cardiology, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, in Paris, France
Professor of Pharmacology at the Faculty of Medicine of the Complutense University of Madrid, Madrid, Spain
Associate Professor, Clinical & Pharmacy Practice, Cardiology Specialist Pharmacist, Department of Pharmacy, National University of Singapore
As we will be asking for your input on a number of existing clinical trials and guidelines during the survey, you may find it helpful to familiarise yourself with the following publications. Algorithms and passages from the relevant guidelines will be accessible at specific points throughout the survey.
Register Now For Free